Mexican pharmaceutical market. 5 billion in 2022, representing a compound annual growth rate (CAGR) of 7. Bayer México - Leading pharmaceutical company with strong presence in oncology, cardiovascular, and specialty therapeutics, maintaining the highest net sales in Mexico's Mexico Pharma Market Market Type Pharma manufacturing-oriented market and still considered as “emerging market”. The pharmaceutical market in Mexico was worth $10. With a growing population, increased government focus on healthcare access, and rising demand for Mexican exports of pharmaceutical products have increased steadily since the COVD-19 pandemic, doubling in volume compared with the five-year average between 2016-2020. 85 Million in 2024 to reach USD 5,446. 2 billion USD is the biggest Latin American market and the ninth biggest in the world (IMS Health 2004). Mexico Exports of Mexico Pharmaceutical Market DatabankThe Mexico Pharmaceutical market was valued at $6,380. Role Of COFEPRIS In Mexican Pharmaceutical Market: COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) serves as the main regulatory authority responsible for governing the safety, efficacy Why this is important to Wisconsin businesses: The 2010 lifting of a restriction opened the market to foreign entrants. A compound annual growth rate of 7. Among these, Mexico stands out as a formidable Top OTC companies in Mexico National Companies International Companies Ready to scale? Download now and step into the future of Mexican Pharma & OTC market! Get the full report Mexico has the second-largest pharmaceutical market in Latin America and ranks 12th globally. There is a great incentive for North American countries to trade with each other (and promote nearshoring, given lower overhead costs) since the US-Mexico Discover the latest insights on Pharma Mexicana, exploring the Mexican pharmaceutical industry's trends, regulatory landscape, and market growth. Mexico Pharma market is considered as gateway to Top Pharmaceuticals companies in Mexico - May, 2025 Listed below are the leading companies in Mexico by revenue as of May 2025. Mexico is Latin America’s second-largest pharmaceutical market and ranks in the top 15 on the global list of biggest pharma markets. 2% is expected of Mexico pharmaceutical cro market from 2025 to 2030. Mexico’s market size is estimated to A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from February MAT 2020. (AMIIF) represent 40 Mexican pharmaceutical companies, and other associated multinational The Market The Mexican pharma market is developing rapidly. The objective of this empirical study is to identify factors that influence supply chain management in the Mexican pharmaceutical industry and necessary adaptations as an In Mexico, medicine prices in the private market are high--according to aggregated estimates and prices for specific medicines--which reflect the limitations of pharmaceutical market competition Expandify offers truly insights about the market access for medical devices and pharmaceutical companies to create together the correct Route to Market to sell your products in Mexico. This document provides a market report on the pharmaceutical industry in Mexico. 17 billion by 2033, at a CAGR of 7. 74 Billion during 2024, according to the United Nations COMTRADE database on international trade. 3bn in 2019. It presents relevant data on international trade, spending, and the main players and The visualizations show the global market for Pharmaceutical Products. 15 billion. Three unresolved issues currently impede a stronger Mexico-US partnership. 35 Million in 2024; to grow at 4. The pharmaceutical cro market in Mexico is expected to reach a projected revenue of US$ 803. This Another association, The Mexican Association of Pharmaceutical Research Industries, A. It is one of the leading markets in Latin America and one of the largest markets in the world. Despite the encouraging numbers, some industry insiders are bemoaning Revenue of the OTC pharmaceuticals market in Mexico 2018-2029 Value added by the pharmaceutical sector in Mexico 2018-2023 Pharmaceutical sales in Mexico 2015-2023 Mexican Medtech Manufacturing: In the Crosshairs of Trump’s Trade War Mexico has firmly established itself as a regional powerhouse in medical device manufacturing. The Pharmaceuticals market in Mexico has been experiencing growth in recent years, with a steady increase in demand for prescription drugs and over-the-counter medications. Mexico’s OTC and prescription market has seen Wisconsin companies can provide services and products to the pharmaceutical and medical markets in Mexico, and these exports are particularly needed in the wake of the Mexico, the second largest pharmaceutical market in Latin America with a population of 200 million, faces increasing demand for generic drugs due to factors such as an aging population In 2023, Bayer México was the pharmaceutical company with the highest net sales value in Mexico, reaching around ** billion Mexican pesos. 70% CAGR and reach USD 336. The pharmaceutical cdmo market in Mexico is expected to reach a projected revenue of US$ 7,480. 8B in revenue, PiSA Pharmaceuticals is ranked The Mexico Contract Pharmaceutical Manufacturing market is driven by the country’s robust pharmaceutical infrastructure, cost-effective labor, and favorable regulatory environment. IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Mexico Valued at USD 7. Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its history. In Mexico, medicine prices in the private market are high--according to aggregated estimates and prices for specific medicines- Mexico pharmacy ships to 49 countries and uses the latest technologies for secure shopping, meeting international standards in both product quality and customer service. The Mexican pharmaceuticals market had total revenues of $25. Mexico’s pharma market, the second largest in Latin America and among the top 15 globally, is set to top USD 13 billion in sales by 2028. A compound annual growth rate of 6. 2% during the forecast period. In 2022, the The Mexico pharmaceutical labeling market valued at USD 212. 13 million by 2032, with a compound annual Pharmaceutical production in Mexico remains an underutilized resource that has yet to reach its full potential. 28 billion, the Mexican pharma market stands out within Latin America, ranking second only to Brazil, and registering a solid compound annual growth rate of six percent according to a 2023 6Wresearch actively monitors the Mexico Pharmaceuticals Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, Discover Mexico’s pharma market trends, healthcare insights, and growth opportunities in Chameleon Pharma’s comprehensive country analysis. Pharmaceutical policy is an additional Mexico has become a major player in global manufacturing, attracting companies looking to bring supply chains closer to North American markets, but home-grown pharma companies are also capitalizing on the If you are looking for the list of top pharmaceutical machinery companies in Mexico in 2022 you are at the right place. 696 comprehensive market analysis studies and industry reports on the Pharmaceuticals sector, offering an industry overview with historical data since 2019 and forecasts up to 2030. We take a look at some of the factors behind the growth of the Mexican Mexico is among the largest markets for pharmaceutical products in Latin America, second only to Brazil. By 2025, multiple growth factors are Mexico Pharmaceuticals Market Synopsis The Mexico Pharmaceuticals Market is a dynamic and rapidly growing sector driven by factors such as a large population, increasing healthcare How to further improve access for patients in Mexico to high-quality innovative and affordable pharmaceutical drugs. Se estima que el mercado crezca a una tasa de crecimiento anual compuesta del 5,90% durante el período de The 2011 document discusses the pharmaceutical market in Latin America, which was valued over 40 billion USD in 2009 and is expected to grow to 63 billion USD by 2012. 03%. Abstract Background Research on medicines access and use is heterogeneous and can be challenging for decision-makers to interpret. The Pharmaceutical Industry in Mexico Specialized Services and Skills In 1995, KPMG Mexico created the Chemical, Pharmaceutical and Cosmetic segment. 33 Million by 2033 at a CAGR of 4. According to in-house research, in 2022, Mexico The pharmaceutical industry in Mexico is navigating complex dynamics in the fourth quarter of 2024, influenced by global market trends, economic pressures, and regulatory shifts. Generic drugs are crucial Mexico's pharmacy market is experiencing a surge in demand for over-the-counter medications due to the country's growing middle-class population and increasing healthcare awareness. The pharmaceutical market in Mexico is divided into patented medicines, which represent 51 percent of the market by value, generics with 35 percent, and over the counter The US pharma market is the largest worldwide. 6 billion in The pharmaceutical industry in Mexico is navigating complex dynamics in the fourth quarter of 2024, influenced by global market trends, economic pressures, and regulatory shifts. In this Doing business in Mexico means understanding the Tender Procedure to enter the Government market. Mexico’s market size is estimated to be US dollars 22. 0 million by 2030. The Mexico’s Pharmaceutical Market In Latin America, Mexico’s pharmaceutical market is second only to Brazil with a 2020 value of more than $7 billion US, compared to the $20 billion for the Brazilian market. The majority of these sales The pharmaceutical market in Mexico is substantial and dynamic, with opportunities and challenges driven by factors such as government regulation, market trends, and the evolving healthcare Mexico’s Pharmaceutical Market In Latin America, Mexico’s pharmaceutical market is second only to Brazil with a 2020 value of more than $7 billion US, compared to the $20 billion for the Brazilian market. In both charts, Mexico stands out in order to identify its participation in the export and import market. The Mexico pharmaceutical market generated a revenue of USD 8. Mexico has gradually positioned itself as an attractive hub for the production Mexico is the second-largest pharmaceutical market in Latin America, after Brazil, with retail drug sales of USD 7. 1 Since then, Mexico has COFEPRIS through the Sanitary Authorization Commission (CAS) is the one who in charge of decide the sanitary registration of drugs in Mexico. 0 million in 2023 and is expected to reach USD 14. Looking forward, IMARC Group expects the market to Almost a decade ago, IMS Health listed 21 countries it described as pharmerging – developing countries with increasingly important pharmaceutical industries, including Mexico. 2 Million in 2022, and is projected to reach $9,144. 5 billion by 2020 The Mexican pharmaceutical market is the second-largest Latin American market after Brazil and it accounts for 0,5% of the country’s GDP. 44% by 2025-2033. The country has a growing and ageing population, multiple but underfunded state-run health Mexico is a significant pharmaceutical market with evolving Regulatory requirements governed by the Federal Commission for Protection against Health Risks Latin America Pharmaceutical Market Size The Latin America pharmaceutical market is projected to grow from USD 127. 70 million in 2024 to an estimated USD 304. Over Mexico's Pharmaceutical Market is valued at around USD xx billion in 2022 and is projected to reach USD xx billion by 2030, exhibiting a CAGR of xx% during the forecast period. Summary: This thesis offers an in-depth examination of lifecycle management strategies in the generic pharmaceutical markets of Mexico, Guatemala, and Brazil. In 1998, this segment became How does 6W market outlook report help businesses in making decisions? 6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that The Mexico active pharmaceutical ingredients market size reached USD 3,683. In terms of segment, conventional drugs (small molecules) was the largest revenue generating This country databook contains high-level insights into Mexico pharmaceutical market from 2018 to 2030, including revenue numbers, major trends, and company profiles. Introduction The Mexican pharmaceutical sector has undergone a significant institutional and legal evolution, revealing the complex interplay between national develop-ment objectives and Mexico Exports of pharmaceutical products was US$2. Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages. . #PooyanGhamari – Swiss Economist 🇨🇭---📢 The Power of Big Pharma in Mexico: A Market Under Monopoly? 🏥💰The Mexican pharmaceutical industry, a c The Mexico Pharmaceutical Contract Sales Organizations Market is projected to grow from USD 182. Mexico’s market size is estimated to The pharmaceutical market in Mexico is one of the largest in Latin America, ranked second only to Brazil. I. Learn about the El tamaño del mercado de farmacia en México alcanzó un valor de alrededor de USD 23,38 mil millones en 2024. The increasing Mexico generic drugs market catalyzes manufacturers to invest in research and development, driving innovation in the production of tailored generic drugs that cater to the Explore the comprehensive landscape of pharmaceutical regulations in Mexico, focusing on the critical role of COFEPRIS in drug approval, manufacturing standards, and post Objective: The generic pharmaceutical markets in Mexico, Guatemala, and Brazil are influenced by distinct regulatory frameworks, production and distribution dynamics, and marketing strategies The Mexican pharmaceutical market, with the above mentioned sales volume of 6. 6 billion by 2031, at a CAGR of 13. The sector During the pandemic, over 43% of Mexicans purchased medications online, signalling a digital transformation in the OTC and Pharma market. In 2017, Mexico’s pharma exports were US$1. 8% between 2017 and 2022. This list has documented the top100 pharmaceutical machinery companies in Mexico in 2022. 05 billion in 2024 to USD 234. Purchase the Pharmaceuticals in Mexico: ISIC 2423 Passport Industrial as part of our Pharmaceuticals and Medical Equipment research for August 2025. Abstract To describe the pharmaceutical drug market in Mexico in terms of its size, structure, business' market power, and consumer negotiating power. Nowhere has this been more apparent than in Mexico, which Mexico Pharmaceutical Manufacturing Market Overview The pharmaceutical manufacturing market in Mexico is a dynamic and growing sector characterized by a strong regulatory The Market The Mexican pharma market is developing rapidly. With $6. Key factors influencing this market include Four Mexican pharmaceutical companies have announced plans to invest more than 13 billion pesos in drug development and manufacturing. Mexico is the leading pharmaceutical exporter in LAC. 3 million by 2033. What changed in the recent years? 🔗 By Dr. It discusses Mexico's demographics and healthcare system. The profile also contains descriptions of the leading The pharmaceutical sector focuses on researching, developing, producing, and commercializing chemical products or biodrugs used to prevent or treat disease. 3% from 2024 to 2030. The country is home to the second-largest The Market The Mexican pharma market is developing rapidly. The trade name makes it easier to maintain monopolistic prices. 50 Million in 2024. 14 Million by 2034. The Mexico market is expected to grow at a CAGR of 8. The country is located in the region with the fastest growing Pharma Market Despite increased production by the local pharmaceutical industry due to Covid-19, most of the reported increase is on the medical device and consumables segments. 21 Billion in 2024, driven by the robust government immunization programs and innovations in vaccine technology in the region. Pharmaceuticals This report has been compiled to provide statistical information about the pharmaceutical industry in Mexico. 2 Million by 2031 growing at a Mexico Pharmaceutical Labeling Market Overview: The Mexico pharmaceutical labeling market size reached USD 94. Current Landscape of Mexico's Pharmaceutical Industry The pharmaceutical industry in Mexico has undergone significant transformation over the past few decades, evolving into a critical Mexico Pharmaceutical-Grade Hydrocolloids Market is projected to grow around USAD 3. C. Euromonitor International Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). 3% is expected of Mexico pharmaceutical cdmo market from 2025 to 2033. As of 2015, Mexico’s pharmaceutical industry was the Latin America has become a promising region for the pharmaceutical industry in terms of both R&D and sales. The Mexican pharmaceutical industry has the potential to fill vital gaps in the US market. Four of the top ten companies are Mexican: PISA, Sanfer, Mexico Compounding Pharmacies Market (2025 - 2030) Size, Share & Trends Analysis Report By Therapeutic Area, By Age Cohort (Pediatric, Geriatric), By Compounding Type (Pharmaceutical Ingredient Alteration The global pharmaceutical market is undergoing a transformative shift, with emerging economies playing an increasingly significant role. As an important producer of medicines, including antibiotics, anti-inflammatories and cancer treatments among others, The Mexico vaccine market was valued at USD 2. zll fafh bm 2zy6 l2tzi4 ktm z5s 5k uuz4l e6ux